Ebenbuild
2 known investors
Find your way into Ebenbuild
Ebenbuild develops personalized, predictive digital twins for patients with severe illness, using computational models grounded in physics, physiology, biochemistry, and disease mechanisms. The company applies this digital twin technology to healthcare and life sciences to support more individualized and efficient patient care.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountfirst financing roundFeb 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ebenbuild do?
- Ebenbuild develops personalized, predictive digital twins for patients with severe illness, using computational models grounded in physics, physiology, biochemistry, and disease mechanisms. The company applies this digital twin technology to healthcare and life sciences to support more individualized and efficient patient care.
- Who are Ebenbuild's investors?
- Ebenbuild's investors include Bayern Kapital, TechFounders.
